Bright Health Group, Inc. (“Bright Health” or the “Company”) (NYSE: BHG), the technology enabled, value-driven healthcare company serving aging and underserved consumers with unmet clinical needs, today reported financial results for its second quarter ended June 30, 2023.
“Bright Health showed continued strong performance in the Second Quarter, including reporting our first quarter with positive Adjusted EBITDA. Our Care Delivery and Care Solutions operating segments both performed well, with each generating positive Operating Income in the quarter,” said Mike Mikan, President and CEO of Bright Health. “Additionally, we expect the sale of our California Medicare Advantage announced at the end of the Second Quarter will bolster our Balance Sheet to continue on our path to long-term profitable growth.”
Key Metrics
As of June 30, | |||
2023 | 2022 | ||
Consumer and Patient Metrics | |||
Value-Based Consumers served1 | 371,000 | 118,000 |
1The value-based care consumers at June 30, 2022 have been recast for comparability to exclude approximately 384,000 consumers attributable to our Bright HealthCare- Commercial business that we exited beginning in 2023. |
Three Months Ended | Six Months Ended | ||||||||||||||
($ in thousands) | June 30 | June 30 | |||||||||||||
2023 | 2022 | 2023 | 2022 | ||||||||||||
Financial Metrics | |||||||||||||||
Revenue | $ | 297,982 | $ | 149,340 | $ | 598,532 | | $ | 330,104 | ||||||
Net Loss from Continuing Operations | $ | (31,692 | ) | $ | (74,762 | ) | $ | (85,610 | ) | | $ | (196,340 | ) | ||
Adjusted EBITDA (non-GAAP) | $ | 6,413 | $ | (23,277 | ) | $ | 670 | $ | (44,758 | ) |
See the table at the end of this release for additional information and a reconciliation of the non-GAAP measures used in the table above.
Financial Outlook
For full year 2023, Bright Health is providing the following guidance and commentary:
Bright Health is revising its 2023 financial outlook to reflect the movement of our California Medicare Advantage business to Held for Sale accounting.
- Bright Health’s Enterprise Revenue is expected to be between $1.15 billion and $1.2 billion
- On a segment basis, Care Solutions Revenue is expected to be between $900 million and $925 million, while Care Delivery Revenue is expected to be between $250 million and $275 million
- Enterprise Adjusted Operating Cost Ratio is expected to be between 17.5% and 18.5%†
- Bright Health expects to be Adjusted EBITDA profitable in 2023†
† Reconciliations of projected Adjusted EBITDA and projected Adjusted Operating Cost Ratio to the most directly comparable GAAP financial measures are not provided because the Company is unable to provide such reconciliations without unreasonable effort. The inability to provide a reconciliation is due to the uncertainty and inherent difficulty predicting the occurrence, the financial impact and the periods in which the non-GAAP adjustments may be recognized. With respect to Adjusted EBITDA, these GAAP measures may include the impact of such items as interest expense, income tax expense, transaction costs, depreciation and amortization, share-based compensation expense, impairment of goodwill or intangible assets, restructuring costs, contract termination costs, changes in the fair value of contingent consideration, changes in the fair value of equity securities; and the tax effect of all such items. Historically, the Company has excluded these items from non-GAAP financial measures. With respect to Adjusted Operating Cost Ratio, these GAAP measures may include the impact of such items as share-based compensation and the impact of investment income. The Company currently expects to continue to exclude these items in future disclosures of non-GAAP financial measures and may also exclude other items that may arise (collectively, “non-GAAP adjustments”). The decisions and events that typically lead to the recognition of non-GAAP adjustments, such as a decision to exit part of the business, are inherently unpredictable as to if or when they may occur. For the same reasons, the Company is unable to address the probable significance of the unavailable information, which could be material to future results.
Earnings Conference Call
As previously announced, Bright Health Group will discuss the Company’s results, strategy, and outlook on a conference call with investors at 8:00 a.m. Eastern Time today. Bright Health Group will host a live webcast of this conference call which can be accessed from the Investor Relations page of the company’s website (investors.brighthealthgroup.com). Following the call, a webcast replay will be available on the same site. This earnings release and the Form 8-K filed August 9, 2023 can be accessed on the Investor Relations page of the Company’s website. We routinely post important information on our website, including corporate and investor presentations and financial information. We intend to use our website as a means of disclosing material, non-public information and for complying with our disclosure obligations under Regulation FD. Such disclosures will be included in the Investor Relations section of our website. Accordingly, investors should monitor this portion of our website, in addition to following our press releases, U.S. Securities and Exchange Commission (“SEC”) filings and public conference calls and webcasts.
About Bright Health Group
Bright Health Group is a technology enabled, value-driven healthcare company that organizes and operates networks of affiliate care providers to be successful at managing population risk. We focus on serving aging and underserved consumers that have unmet clinical needs through our Fully Aligned Care Model in Florida, Texas and California, some of the largest markets in healthcare where 26% of the U.S. aging population call home. We believe everyone should have access to personal, affordable, and high-quality healthcare. Our mission is to Make healthcare right. Together. For more information, visit www.brighthealthgroup.com.
Forward-Looking Statements
Statements made in this release that are not statements of historical fact, including statements about our beliefs and expectations, are forward-looking statements and should be evaluated as such. Forward-looking statements include information concerning possible or assumed future results of operations, including descriptions of our business plan and strategies. These statements often include words such as “anticipate,” “expect,” “plan,” “believe,” “intend,” “project,” “forecast,” “estimates,” “projections,” “outlook,” “ensure,” and other similar expressions. These forward-looking statements include any statements regarding our plans and expectations with respect to Bright Health Group, Inc. Such forward-looking statements are subject to various risks, uncertainties and assumptions. Accordingly, there are or will be important factors that could cause actual outcomes or results to differ materially from those indicated in these statements. Factors that might materially affect such forward-looking statements include: our ability to continue as a going concern; our ability to comply with the terms of our credit facilities, including financial covenants, both during and after any applicable waiver period, and/or obtain any additional waivers of any terms of our credit facilities to the extent required; our ability to sell our Medicare Advantage business in California on acceptable terms, including our ability to receive the proceeds thereof in a manner that would alleviate our current financial position; the failure to satisfy or obtain any waiver, if applicable, of any closing condition in our agreement to sell our Medicare Advantage business in California to Molina (the “Purchase Agreement”); our ability to comply with the terms of the Purchase Agreement; whether our new credit facility will satisfy our working capital needs pending the closing of our sale of our Medicare Advantage business in California; our ability to obtain any additional short or long term debt or equity financing needed to operate our business; our ability to quickly and efficiently wind down our IFP businesses and MA businesses outside of California, including by satisfying liabilities of those businesses when due and payable; ; potential disruptions to our business due to our corporate restructuring and resulting headcount reduction; our ability to accurately estimate and effectively manage the costs relating to changes in our businesses offerings and models; a delay or inability to withdraw regulated capital from our subsidiaries; a lack of acceptance or slow adoption of our business model; our ability to retain existing consumers and add new consumers; our and our Care Partner’s abilities to obtain and accurately assess, code, and report risk adjustment factor scores; our ability to contract with care providers and arrange for the provision of quality care; our ability to accurately estimate our medical expenses, effectively manage our costs and claims liabilities or appropriately price our products and charge premiums; our ability to obtain claims information timely and accurately; the impact of the ongoing COVID-19 pandemic on our business and results of operations; the risks associated with our reliance on third-party providers to operate our business; the impact of modifications or changes to the U.S. health insurance markets; our ability to manage the growth of our business; our ability to operate, update or implement our technology platform and other information technology systems; our ability to retain key executives; our ability to successfully pursue acquisitions and integrate acquired businesses; the occurrence of severe weather events, catastrophic health events, natural or man-made disasters, and social and political conditions or civil unrest; our ability to prevent and contain data security incidents and the impact of data security incidents on our members, patients, employees and financial results; our ability to comply with requirements to maintain effective internal controls; our ability to adapt to the new risks associated with our expansion into ACO REACH; and the other factors set forth under the heading “Risk Factors” in the Company’s reports on Form 10-K, Form 10-Q, and Form 8-K (including all amendments to those reports) and our other filings with the SEC. Except as required by law, we undertake no obligation to update publicly any forward-looking statements for any reason after the date of this release to conform these statements to actual results or changes in our expectations.
Bright Health Group, Inc. and Subsidiaries | |||||||
Consolidated Balance Sheets | |||||||
(in thousands, except share and per share data) | |||||||
(Unaudited) | |||||||
June 30,
| December 31,
| ||||||
Assets | |||||||
Current assets: | |||||||
Cash and cash equivalents | $ | 107,660 | $ | 217,006 | |||
Short-term investments | $ | 156 | 869 | ||||
Accounts receivable, net of allowance of $7,653 and $6,098, respectively | $ | 27,633 | 19,576 | ||||
ACO REACH performance year receivable | $ | 623,609 | 99,181 | ||||
Current assets of discontinued operations (Note 14) | $ | 3,030,870 | 3,187,464 | ||||
Prepaids and other current assets | 61,198 | 46,538 | |||||
Total current assets | 3,851,126 | 3,570,634 | |||||
Other assets: | | ||||||
Long-term investments | $ | 344 | 5,401 | ||||
Property, equipment and capitalized software, net | $ | 18,474 | 21,298 | ||||
Goodwill | $ | 401,385 | 401,385 | ||||
Intangible assets, net | $ | 99,084 | 104,952 | ||||
Long-term assets of discontinued operations (Note 14) | $ | — | 529,117 | ||||
Other non-current assets | 22,740 | 32,265 | |||||
Total other assets | 542,027 | 1,094,418 | |||||
Total assets | $ | 4,393,153 | $ | 4,665,052 | |||
Liabilities, Redeemable Noncontrolling Interest, Redeemable Preferred Stock and Shareholders’ Equity (Deficit) | | ||||||
Current liabilities: | | ||||||
Medical costs payable | $ | 179,855 | $ | 116,021 | |||
Accounts payable | $ | 18,476 | 18,714 | ||||
ACO REACH performance year obligation | $ | 474,700 | — | ||||
Short-term borrowings | $ | 303,947 | 303,947 | ||||
Current liabilities of discontinued operations (Note 14) | $ | 2,584,890 | 3,157,236 | ||||
Other current liabilities | 73,221 | 97,241 | |||||
Total current liabilities | 3,635,089 | 3,693,159 | |||||
Other liabilities | 28,792 | 32,208 | |||||
Total liabilities | 3,663,881 | 3,725,367 | |||||
Commitments and contingencies (Note 9) | | | |||||
Redeemable noncontrolling interests | $ | 244,561 | 219,758 | ||||
Redeemable Series A preferred stock, $0.0001 par value;750,000 shares authorized in 2023 and 2022; 750,000 shares issued and outstanding in 2023 and 2022 | $ | 747,481 | 747,481 | ||||
Redeemable Series B preferred stock, $0.0001 par value; 175,000 shares authorized in 2023 and 2022; 175,000 shares issued and outstanding in 2023 and 2022 | $ | 172,936 | 172,936 | ||||
Shareholders’ equity (deficit): | |||||||
Common stock, $0.0001 par value; 3,000,000,000 shares authorized in 2023 and 2022; 7,972,033 and 7,878,394 shares issued and outstanding in 2023 and 2022*, respectively | $ | 1 | 1 | ||||
Additional paid-in capital | $ | 3,021,430 | 2,972,333 | ||||
Accumulated deficit | $ | (3,444,238 | ) | (3,156,395 | ) | ||
Accumulated other comprehensive loss | $ | (899 | ) | (4,429 | ) | ||
Treasury Stock, at cost, 31,526 shares at June 30, 2023, and December 31, 2022*, respectively | (12,000 | ) | (12,000 | ) | |||
Total shareholders’ equity (deficit) | (435,706 | ) | (200,490 | ) | |||
Total liabilities, redeemable noncontrolling interests, redeemable preferred stock and shareholders’ equity (deficit) | $ | 4,393,153 | $ | 4,665,052 |
*Shares have been retroactively adjusted to reflect the decreased number of shares resulting from a 1 for 80 reverse stock split |
Bright Health Group, Inc. and Subsidiaries | |||||||||||||||
Consolidated Statements of Income (Loss) | |||||||||||||||
(in thousands, except share and per share data) | |||||||||||||||
(Unaudited) | |||||||||||||||
| Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||
| 2023 | 2022 | 2023 | 2022 | |||||||||||
Revenue: | | | |||||||||||||
Capitated revenue | $ | 49,764 | $ | 17,641 | $ | 99,312 | $ | 46,289 | |||||||
ACO REACH revenue | 236,994 | 137,205 | 476,801 | 320,002 | |||||||||||
Service revenue | 11,222 | 10,732 | 22,409 | 20,962 | |||||||||||
Investment income (loss) | 2 | (16,238 | ) | 10 | (57,149 | ) | |||||||||
Total revenue | 297,982 | 149,340 | 598,532 | 330,104 | |||||||||||
Operating expenses: | | | | ||||||||||||
Medical costs | 245,160 | 130,793 | 505,280 | 310,249 | |||||||||||
Operating costs | 70,280 |